Jump to content

Transcranial direct-current stimulation

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 13:16, 22 June 2020 (Open access bot: hdl, doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Transcranial direct-current stimulation
Anodal tDCS administration. Anodal (b) and cathodal (c) electrodes with 35-cm2 size are put on F3 and right supraorbital region, respectively. A head strap is used (d) for convenience and reproducibility, and a rubber band (e) for reducing resistance.
MeSHD065908

Transcranial direct current stimulation (tDCS) is a form of neuromodulation that uses constant, low direct current delivered via electrodes on the head. It was originally developed to help patients with brain injuries or psychiatric conditions like major depressive disorder. It can be contrasted with cranial electrotherapy stimulation, which generally uses alternating current the same way.[1]

Research shows increasing evidence for tDCS as a treatment for depression.[2][3][4] There is mixed evidence about whether tDCS is useful for cognitive enhancement in healthy people. There is no good evidence that tDCS is useful for memory deficits in Parkinson's disease and Alzheimer's disease,[5] schizophrenia,[6] non-neuropathic pain,[7] or improving upper limb function after stroke.[8][9]

tDCS efficacy in medical use

Depression

In 2015, the British National Institute for Health and Care Excellence (NICE) found tDCS to be safe and to appear effective for depression treatment, although more and larger studies was needed at that point.[4] Since then, several studies and meta-analysis have been conducted that add to the evidence of tDCS as a safe and effective treatment for depression.[2][3]

A meta-analysis was published in 2020 summarising results across nine eligible studies (572 participants), presenting moderate/high certainty of evidence. Active tDCS was significantly superior to sham for response (30.9% vs. 18.9% respectively), remission (19.9% vs. 11.7%) and depression improvement.[10] According to a 2016 meta analysis published in the British Journal Psychology, 34% of tDCS-treated patients showed at least 50% symptom reduction (compared to 19% placebo) across 6 randomised controlled trials.[11]

Other medical use

Recent research on tDCS has shown promising results in treating other mental health conditions such as anxiety[12] and PTSD.[13] More research is required on the topic. There is also evidence that tDCS is useful in treating neuropathic pain after spinal cord injury [14] and improving activities of daily living assessment after stroke.[15]

tDCS safety - adverse effects and contraindications

According to the British National Institute for Health and Care Excellence (NICE), the evidence on tDCS for depression raises no major safety concerns.[16]  

As of 2017, at stimulation up to 60 min and up to 4 mA over two weeks, adverse effects include skin irritation, a phosphene at the start of stimulation, nausea, headache, dizziness, and itching under the electrode. Typical treatment sessions lasting for about 20–30 minutes repeated daily for several weeks in the treatment of depression.[17] Adverse effects of long term treatment were not known as of 2017.[18] Nausea most commonly occurs when the electrodes are placed above the mastoid for stimulation of the vestibular system. A phosphene is a brief flash of light that can occur if an electrode is placed near the eye.[19][20]

People susceptible to seizures, such as people with epilepsy should not receive tDCS.[19] Studies have been completed to determine the current density at which overt brain damage occurs in rats. It was found that in cathodal stimulation, a current density of 142.9 A/m2 delivering a charge density of 52400 C/m2 or higher caused a brain lesion in the rat. This is over two orders of magnitude higher than protocols that were in use as of 2009.[21][22][23]

Mechanism of action

tDCS stimulates and activates brain cells by delivering electrical signals. The way that the stimulation changes brain function is either by causing the neuron’s resting membrane potential to depolarize or hyperpolarize. When positive stimulation (anodal tDCS) is delivered, the current causes a depolarization of the resting membrane potential, which increases neuronal excitability and allows for more spontaneous cell firing. When negative stimulation (cathodal tDCS) is delivered, the current causes a hyperpolarization of the resting membrane potential. This decreases neuron excitability due to the decreased spontaneous cell firing.[19][24]

In case of treating depression, tDCS currents specifically target the left side of dorsolateral prefrontal cortex (DLPFC) located in the frontal lobe. Left DLPFC has been shown to be associated with lower activity in the depressed population.[25][10]

One of the aspects of tDCS is its ability to achieve cortical changes even after the stimulation is ended. The duration of this change depends on the length of stimulation as well as the intensity of stimulation. The effects of stimulation increase as the duration of stimulation increases or the strength of the current increases.[26] tDCS has been proposed to promote both long term potentiation and long term depression,[19][24] and further research is needed for validation.

Operation

Transcranial direct current stimulation works by sending constant, low direct current through the electrodes. When these electrodes are placed in the region of interest, the current induces intracerebral current flow. This current flow then either increases or decreases the neuronal excitability in the specific area being stimulated based on which type of stimulation is being used. This change of neuronal excitability leads to alteration of brain function, which can be used in various therapies as well as to provide more information about the functioning of the human brain.[19]

Parts

Transcranial direct current stimulation is a relatively simple technique requiring only a few parts. These include two electrodes and a battery-powered device that delivers constant current. Control software can also be used in experiments that require multiple sessions with differing stimulation types so that neither the person receiving the stimulation nor the experimenter knows which type is being administered. Each device has an anodal, positively charged electrode and a cathodal, negative electrode. Current is "conventionally" described as flowing from the positive anode, through the intervening conducting tissue, to the cathode, creating a circuit. Note that in traditional electric circuits constructed from metal wires, current flow is created by the motion of negatively charged electrons, which actually flow from cathode to anode. However, in biological systems, such as the head, current is usually created by the flow of ions, which may be positively or negatively charged—positive ions will flow towards the cathode; negative ions will flow toward the anode. The device may control the current as well as the duration of stimulation.[27]

Setup

To set up the tDCS device, the electrodes and the skin need to be prepared. This ensures a low resistance connection between the skin and the electrode. The careful placement of the electrodes is crucial to successful tDCS technique. The electrode pads come in various sizes with benefits to each size. A smaller sized electrode achieves a more focused stimulation of a site while a larger electrode ensures that the entirety of the region of interest is being stimulated.[28] If the electrode is placed incorrectly, a different site or more sites than intended may be stimulated resulting in faulty results.[19] One of the electrodes is placed over the region of interest and the other electrode, the reference electrode, is placed in another location in order to complete the circuit. This reference electrode is usually placed on the neck or shoulder of the opposite side of the body than the region of interest. Since the region of interest may be small, it is often useful to locate this region before placing the electrode by using a brain imaging technique such as fMRI or PET.[19] Once the electrodes are placed correctly, the stimulation can be started. Many devices have a built-in capability that allows the current to be "ramped up" or increased gradually until the necessary current is reached. This decreases the amount of stimulation effects felt by the person receiving the tDCS.[29] After the stimulation has been started, the current will continue for the amount of time set on the device and then will automatically be shut off. Recently a new approach has been introduced where instead of using two large pads, multiple (more than two) smaller sized gel electrodes are used to target specific cortical structures. This new approach is called High Definition tDCS (HD-tDCS).[28][30] In a pilot study, HD-tDCS was found to have greater and longer lasting motor cortex excitability changes than sponge tDCS.[31]

Types of stimulation

There are three different types of stimulation: anodal, cathodal, and sham. The anodal stimulation is positive (V+) stimulation that increases the neuronal excitability of the area being stimulated. Cathodal (V-) stimulation decreases the neuronal excitability of the area being stimulated. Cathodal stimulation can treat psychiatric disorders that are caused by the hyper-activity of an area of the brain.[32] Sham stimulation is used as a control in experiments. Sham stimulation emits a brief current but then remains off for the remainder of the stimulation time. With sham stimulation, the person receiving the tDCS does not know that they are not receiving prolonged stimulation. By comparing the results in subjects exposed to sham stimulation with the results of subjects exposed to anodal or cathodal stimulation, researchers can see how much of an effect is caused by the current stimulation, rather than by the placebo effect.

At-home administration of tDCS

Recently, tDCS devices are being researched and created intended for at-home use - ranging from treating medical conditions such as depression to enhancing general cognitive well-being.[33][34]

History

The basic design of tDCS, using direct current (DC) to stimulate the area of interest, has existed for over 100 years. There were a number of rudimentary experiments completed before the 19th century using this technique that tested animal and human electricity. Luigi Galvani and Alessandro Volta were two such researchers that utilized the technology of tDCS in their explorations of the source of animal cell electricity. It was due to these initial studies that tDCS was first brought into the clinical scene. In 1801, Giovanni Aldini (Galvani's nephew) started a study in which he successfully used the technique of direct current stimulation to improve the mood of melancholy patients.[35]

There was a brief rise of interest in transcranial direct current stimulation in the 1960s when studies by researcher D. J. Albert proved that the stimulation could affect brain function by changing the cortical excitability.[36]: 49–64  He also discovered that positive and negative stimulation had different effects on the cortical excitability.[36]: 65–77  . Research continued, further fueled by knowledge gained from other techniques like TMS and fMRI.[26][19]

Comparison to other devices

Transcranial electrical stimulation techniques. While tDCS uses constant current intensity, tRNS and tACS use oscillating current. The vertical axis represents the current intensity in milliamp (mA), while the horizontal axis illustrates the time-course.

In transcranial magnetic stimulation (TMS), an electric coil is held above the region of interest on the scalp that uses rapidly changing magnetic fields to induce small electrical currents in the brain. There are two types of TMS: repetitive TMS and single pulse TMS. Both are used in research therapy but effects lasting longer than the stimulation period are only observed in repetitive TMS. Similar to tDCS, an increase or decrease in neuronal activity can be achieved using this technique, but the method of how this is induced is very different. Transcranial direct current stimulation has the two different directions of current that cause the different effects. Increased neuronal activity is induced in repetitive TMS by using a higher frequency and decreased neuronal activity is induced by using a lower frequency.[27]

Variants related to tDCS include tACS, tPCS and transcranial random noise stimulation (tRNS), a group of technologies commonly referred to as transcranial electrical stimulation, or TES.[37]

Research

tDCS and depression

Latest research on tDCS has shown increasing evidence for the treatment of depression.

A systematic review of placebo-controlled trials on tDCS was published recently in 2020.[10] The meta-analysis collated results across nine eligible studies (572 participants) up until December 2018 to estimate odds ratio (OR) and number needed to treat (NNT) of response and remission, and depression improvement. The results showed statistically superior efficacy of active tDCS compared to sham for Nine eligible studies (572 participants), presenting moderate/high certainty of evidence, were included. Active tDCS was significantly superior to sham for response (30.9% vs. 18.9% respectively; OR = 1.96, 95%CI [1.30–2.95], NNT = 9), remission (19.9% vs. 11.7%, OR = 1.94 [1.19–3.16], NNT = 13) and depression improvement (effect size of β = 0.31, [0.15–0.47]).

Previously, a 2016 meta-analysis showed that 34% of tDCS-treated patients showed at least 50% symptom reduction (compared to 19% placebo).[11] A 2017 study conducted by Brunoni showed 6-weeks of tDCS treatment resulted in reduction of at least half of depression symptoms in 41% of depressed people (vs. 22% placebo and 47% antidepressants).[38]

In 2015, the British National Institute for Health and Care Excellence (NICE) found tDCS to be safe and to appear effective for depression treatment. Up until 2014, there have been several small randomized clinical trials (RCT) in major depressive disorder (MDD); most found alleviation of depressive symptoms. There have been only two RCTs in treatment-resistant MDD; both were small, and one found an effect and the other did not.[39] One meta-analysis of the data focused on reduction in symptoms and found an effect compared to sham treatment, but another that was focused on relapse found no effect compared to sham.[39]

tDCS beyond depression

In 2016, European meta analysis has found level B evidence (probable efficacy) for fibromyalgia, depression and craving.[40]

There is mixed evidence about whether tDCS is useful for cognitive enhancement in healthy people. Several reviews have found evidence of small yet significant cognitive improvements.[41][42][43][44] Other reviews found no evidence at all,[45][46] although one of them[46] has been criticized for overlooking within-subject effects[47] and evidence from multiple-session tDCS trials. There is no good evidence that tDCS is useful for memory deficits in Parkinson's disease and Alzheimer's disease,[5] schizophrenia,[6] non-neuropathic pain,[7] or improving upper limb function after stroke.[8][9]

A 2015 review of results from hundreds of tDCS experiments found that there was no statistically conclusive evidence to support any net cognitive effect, positive or negative, of single session tDCS in healthy populations - there is no evidence that tDCS is useful for cognitive enhancement.[46] A second study by the same authors found there was little-to-no statistically reliable impact of tDCS on any neurophysiologic outcome.[45]

A few clinical trials have been conducted on the use of tDCS to ameliorate memory deficits in Parkinson's disease and Alzheimer's disease and healthy subjects, with mixed results.[5] A 2016 Cochrane review found evidence that tDSC can improve activities of daily living in Parkinson’s disease but the evidence was very low to moderate quality.[48]

Research conducted as of 2013 in schizophrenia, has found that while large effect sizes were initially found for symptom improvement, later and larger studies have found smaller effect sizes (see also section on use of tDCS in psychiatric disorders below). Studies have mostly concentrated on positive symptoms like auditory hallucinations; research on negative symptoms is lacking.[6] In addition to the tDCS research in depression,[49][50][51][52][53][54] tDCS has been studied in reversing cognitive deficits in schizophrenia.[55] Some researchers are investigating potential applications such as the improvement of focus and concentration.[56] tDCS has also been studied in addiction.[57][58]

Research conducted as of 2012 on the use of tDCS to treat pain, found that the research has been of low quality and cannot be used as a basis to recommend use of tDCS to treat pain.[7] In chronic pain following spinal cord injury, research is of high quality and has found tDCS to be ineffective.[59]

In stroke, research conducted as of 2014, has found that tDCS is not effective for improving upper limb function after stroke.[8][9] While some reviews have suggested an effect of tDCS for improving post-stroke aphasia, a 2015 Cochrane review could find no improvement from combining tDCS with conventional treatment.[60][9][61] Research conducted as of 2013 suggests that tDCS may be effective for improve vision deficits following stroke.[9]

tDCS has also been used in neuroscience research, particularly to try to link specific brain regions to specific cognitive tasks[62] or psychological phenomena.[63] The cerebellum has been a focus of research, due to its high concentration of neurons, its location immediately below the skull, and its multiple reciprocal anatomical connections to motor and associative parts of the brain.[64] Most such studies focus on the impact of cerebellar tDCS on motor, cognitive, and affective functions in healthy and patient populations, but some also employ tDCS over the cerebellum to study the functional connectivity of the cerebellum to other areas of the brain.[65]

Regulatory approvals

tDCS is a CE approved treatment for Major Depressive Disorder (MDD) in the UK, EU, Australia, and Mexico. As of 2015, tDCS has not been approved for any use by the US FDA.[61] An FDA briefing document prepared in 2012 stated that "there is no regulation for therapeutic tDCS".[66]

See also

References

  1. ^ Rosa, MA; Lisanby, SH (January 2012). "Somatic treatments for mood disorders". Neuropsychopharmacology. 37 (1): 102–16. doi:10.1038/npp.2011.225. PMC 3238088. PMID 21976043.
  2. ^ a b Brunoni AR, Moffa AH, Fregni F, Palm U, Padberg F, Blumberger DM, Daskalakis ZJ, Bennabi D, Haffen E, Alonzo A, Loo CK (2016). "Transcranial direct current stimulation for acute major depressive episodes: meta-analysis of individual patient data". The British Journal of Psychiatry. 208 (6): 522–31. doi:10.1192/bjp.bp.115.164715. PMC 4887722. PMID 27056623. Our findings indicates two potential applications for tDCS in the therapeutic arsenal for depression: in primary care settings and as a non-pharmacological, neuromodulatory therapy for depression.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  3. ^ a b Julian Mutz, Vijeinika Vipulananthan, Ben Carter, René Hurlemann, Cynthia H Y Fu, Allan H Young (2019). "Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis". BMJ. 364: l1079. doi:10.1136/bmj.l1079. PMC 6435996. PMID 30917990. we found tDCS to be efficacious across outcomes in both pairwise and network meta-analyses.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ a b "Transcranial direct current stimulation (tDCS) for depression". NICE. August 2015. Retrieved 10 November 2015.
  5. ^ a b c Bennabi D (Sep 2014). "Transcranial direct current stimulation for memory enhancement: from clinical research to animal models". Front Syst Neurosci. 8: 159. doi:10.3389/fnsys.2014.00159. PMC 4154388. PMID 25237299.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ a b c Agarwal SM; et al. (Dec 2013). "Transcranial direct current stimulation in schizophrenia". Clin Psychopharmacol Neurosci. 11 (3): 118–25. doi:10.9758/cpn.2013.11.3.118. PMC 3897759. PMID 24465247.
  7. ^ a b c Luedtke K; et al. (Jun 2012). "Transcranial direct current stimulation for the reduction of clinical and experimentally induced pain: a systematic review and meta-analysis". Clin J Pain. 28 (5): 452–61. doi:10.1097/AJP.0b013e31823853e3. PMID 22569218.
  8. ^ a b c Pollock A; et al. (Nov 2014). "Interventions for improving upper limb function after stroke". Cochrane Database Syst Rev. 11 (11): CD010820. doi:10.1002/14651858.CD010820.pub2. PMC 6469541. PMID 25387001.
  9. ^ a b c d e Feng WW; et al. (Jan 2013). "Review of transcranial direct current stimulation in poststroke recovery". Top Stroke Rehabil. 20 (1): 68–77. doi:10.1310/tsr2001-68. PMID 23340073.
  10. ^ a b c Moffa, Adriano H.; Martin, Donel; Alonzo, Angelo; Bennabi, Djamila; Blumberger, Daniel M.; Benseñor, Isabela M.; Daskalakis, Zafiris; Fregni, Felipe; Haffen, Emmanuel; Lisanby, Sarah H.; Padberg, Frank (2020-04-20). "Efficacy and acceptability of transcranial direct current stimulation (tDCS) for major depressive disorder: An individual patient data meta-analysis". Progress in Neuro-Psychopharmacology and Biological Psychiatry. 99: 109836. doi:10.1016/j.pnpbp.2019.109836. ISSN 0278-5846. PMID 31837388.
  11. ^ a b Brunoni, André R.; Moffa, Adriano H.; Fregni, Felipe; Palm, Ulrich; Padberg, Frank; Blumberger, Daniel M.; Daskalakis, Zafiris J.; Bennabi, Djamila; Haffen, Emmanuel; Alonzo, Angelo; Loo, Colleen K. (June 2016). "Transcranial direct current stimulation for acute major depressive episodes: Meta-analysis of individual patient data". The British Journal of Psychiatry. 208 (6): 522–531. doi:10.1192/bjp.bp.115.164715. ISSN 0007-1250. PMID 27056623.
  12. ^ Stein, Dirson João; Fernandes Medeiros, Liciane; Caumo, Wolnei; Torres, Iraci LS (2020-01-14). "Transcranial Direct Current Stimulation in Patients with Anxiety: Current Perspectives". Neuropsychiatric Disease and Treatment. 16: 161–169. doi:10.2147/NDT.S195840. ISSN 1176-6328. PMC 6969693. PMID 32021208.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  13. ^ Ahmadizadeh, Mohammad Javad; Rezaei, Mehdi; Fitzgerald, Paul B. (November 2019). "Transcranial direct current stimulation (tDCS) for post-traumatic stress disorder (PTSD): A randomized, double-blinded, controlled trial". Brain Research Bulletin. 153: 273–278. doi:10.1016/j.brainresbull.2019.09.011. ISSN 1873-2747. PMID 31560945.
  14. ^ Soler, M. D.; Kumru, H.; Pelayo, R.; Vidal, J.; Tormos, J. M.; Fregni, F.; Navarro, X.; Pascual-Leone, A. (2010-09-01). "Effectiveness of transcranial direct current stimulation and visual illusion on neuropathic pain in spinal cord injury". Brain. 133 (9): 2565–2577. doi:10.1093/brain/awq184. ISSN 0006-8950. PMC 2929331. PMID 20685806.
  15. ^ Elsner, Bernhard; Kwakkel, Gert; Kugler, Joachim; Mehrholz, Jan (2017-09-13). "Transcranial direct current stimulation (tDCS) for improving capacity in activities and arm function after stroke: a network meta-analysis of randomised controlled trials". Journal of NeuroEngineering and Rehabilitation. 14 (1): 95. doi:10.1186/s12984-017-0301-7. ISSN 1743-0003. PMC 5598049. PMID 28903772.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  16. ^ "1 Recommendations | Transcranial direct current stimulation (tDCS) for depression | Guidance | NICE". www.nice.org.uk. Retrieved 2020-05-12.
  17. ^ "3 The procedure | Transcranial direct current stimulation (tDCS) for depression | Guidance | NICE". www.nice.org.uk. Retrieved 2020-05-12.
  18. ^ Poreisz, Csaba; Boros, Klára; Antal, Andrea; Paulus, Walter (2007). "Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients". Brain Research Bulletin. 72 (4–6): 208–14. doi:10.1016/j.brainresbull.2007.01.004. PMID 17452283.
  19. ^ a b c d e f g h Nitsche, Michael A.; Cohen, Leonardo G.; Wassermann, Eric M.; Priori, Alberto; Lang, Nicolas; Antal, Andrea; Paulus, Walter; Hummel, Friedhelm; Boggio, Paulo S.; Fregni, Felipe; Pascual-Leone, Alvaro (2008). "Transcranial direct current stimulation: State of the art 2008". Brain Stimulation. 1 (3): 206–23. doi:10.1016/j.brs.2008.06.004. PMID 20633386.
  20. ^ Antal, A.; Alekseichuk, I.; Bikson, M.; Brockmoeller, J.; Brunoni, A.R.; Chen, R.; Cohen, L.G.; Dowthwaite, G.; Ellrich, J.; Floel, A.; Fregni, F.; George, M.S.; Hamilton, R.; Haueisen, J.; Herrmann, C.S.; Hummel, F.C.; Lefaucheur, J.P.; Liebetanz, D.; Loo, C.K.; McCaig, C.D.; Miniussi, C.; Miranda, P.C.; Moliadze, V.; Nitsche, M.A.; Nowak, R.; Padberg, F.; Pascual-Leone, A.; Poppendieck, W.; Priori, A.; Rossi, S.; Rossini, P.M.; Rothwell, J.; Rueger, M.A.; Ruffini, G.; Schellhorn, K.; Siebner, H.R.; Ugawa, Y.; Wexler, A.; Ziemann, U.; Hallett, M.; Paulus, W. (June 2017). "Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines". Clinical Neurophysiology. 128 (9): 1774–1809. doi:10.1016/j.clinph.2017.06.001. PMC 5985830. PMID 28709880.
  21. ^ Nitsche, Michael A; Liebetanz, David; Lang, Nicolas; Antal, Andrea; Tergau, Frithjof; Paulus, Walter (2003). "Safety criteria for transcranial direct current stimulation (tDCS) in humans". Clinical Neurophysiology. 114 (11): 2220–2, author reply 2222–3. doi:10.1016/S1388-2457(03)00235-9. PMID 14580622.
  22. ^ Liebetanz, David; Koch, Reinhard; Mayenfels, Susanne; König, Fatima; Paulus, Walter; Nitsche, Michael A. (2009). "Safety limits of cathodal transcranial direct current stimulation in rats". Clinical Neurophysiology. 120 (6): 1161–7. doi:10.1016/j.clinph.2009.01.022. PMID 19403329.
  23. ^ Bikson, Marom; Datta, Abhishek; Elwassif, Maged (2009). "Establishing safety limits for transcranial direct current stimulation". Clinical Neurophysiology. 120 (6): 1033–4. doi:10.1016/j.clinph.2009.03.018. PMC 2754807. PMID 19394269.
  24. ^ a b Nitsche, M. A.; Paulus, W. (2000). "Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation". The Journal of Physiology. 527 (3): 633–639. doi:10.1111/j.1469-7793.2000.t01-1-00633.x. PMC 2270099. PMID 10990547.
  25. ^ "Transcranial direct current stimulation in the treatment of depression". Medicographia. 2011-10-24. Retrieved 2020-05-12.
  26. ^ a b Utz, Kathrin S.; Dimova, Violeta; Oppenländer, Karin; Kerkhoff, Georg (2010). "Electrified minds: Transcranial direct current stimulation (tDCS) and Galvanic Vestibular Stimulation (GVS) as methods of non-invasive brain stimulation in neuropsychology—A review of current data and future implications". Neuropsychologia. 48 (10): 2789–810. doi:10.1016/j.neuropsychologia.2010.06.002. PMID 20542047.
  27. ^ a b Sparing, Roland; Mottaghy, Felix M. (2008). "Noninvasive brain stimulation with transcranial magnetic or direct current stimulation (TMS/tDCS)—From insights into human memory to therapy of its dysfunction". Methods. 44 (4): 329–37. doi:10.1016/j.ymeth.2007.02.001. PMID 18374276.
  28. ^ a b Datta, Abhishek; Bansal, Varun; Diaz, Julian; Patel, Jinal; Reato, Davide; Bikson, Marom (2009). "Gyri-precise head model of transcranial direct current stimulation: Improved spatial focality using a ring electrode versus conventional rectangular pad". Brain Stimulation. 2 (4): 201–7, 207.e1. doi:10.1016/j.brs.2009.03.005. PMC 2790295. PMID 20648973.
  29. ^ Viganò, Alessandro; d'Elia, Tullia Sasso; Sava, Simona Liliana; Auvé, Maurie; De Pasqua, Victor; Colosimo, Alfredo; Di Piero, Vittorio; Schoenen, Jean; Magis, Delphine (2013). "Transcranial Direct Current Stimulation (tDCS) of the visual cortex: A proof-of-concept study based on interictal electrophysiological abnormalities in migraine". The Journal of Headache and Pain. 14 (1): 23. doi:10.1186/1129-2377-14-23. PMC 3620516. PMID 23566101.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  30. ^ Borckardt, Jeffrey J.; Bikson, Marom; Frohman, Heather; Reeves, Scott T.; Datta, Abhishek; Bansal, Varun; Madan, Alok; Barth, Kelly; George, Mark S. (2012). "A Pilot Study of the Tolerability and Effects of High-Definition Transcranial Direct Current Stimulation (HD-tDCS) on Pain Perception". The Journal of Pain. 13 (2): 112–20. doi:10.1016/j.jpain.2011.07.001. PMID 22104190.
  31. ^ Kuo, Hsiao-I.; Bikson, Marom; Datta, Abhishek; Minhas, Preet; Paulus, Walter; Kuo, Min-Fang; Nitsche, Michael A. (2013). "Comparing Cortical Plasticity Induced by Conventional and High-Definition 4 × 1 Ring tDCS: A Neurophysiological Study". Brain Stimulation. 6 (4): 644–8. doi:10.1016/j.brs.2012.09.010. PMID 23149292.
  32. ^ Nitsche, Michael A.; Nitsche, Maren S.; Klein, Cornelia C.; Tergau, Frithjof; Rothwell, John C.; Paulus, Walter (2003). "Level of action of cathodal DC polarisation induced inhibition of the human motor cortex". Clinical Neurophysiology. 114 (4): 600–4. doi:10.1016/S1388-2457(02)00412-1. PMID 12686268.
  33. ^ Riggs, Alexa; Patel, Vaishali; Paneri, Bhaskar; Portenoy, Russell K.; Bikson, Marom; Knotkova, Helena (2018-05-22). "At-Home Transcranial Direct Current Stimulation (tDCS) With Telehealth Support for Symptom Control in Chronically-Ill Patients With Multiple Symptoms". Frontiers in Behavioral Neuroscience. 12: 93. doi:10.3389/fnbeh.2018.00093. ISSN 1662-5153. PMC 5972211. PMID 29872381.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  34. ^ Thomson, Helen. "Europe's first home brain-zap device for depression launched in UK". New Scientist. Retrieved 2020-05-12.
  35. ^ André Parent (November 2004). "Aldini's Essay on Galvanism" (PDF). The Canadian Journal of Neurological Sciences. 31 (4): 576–584. (Lanzarini pdf 5 of 9)
    • Aldini J. Essai théorique et expérimental sur le galvanisme, avec une série d’expériences faites devant des commissaires de l’Institut national de France, et en divers amphithéâtres anatomiques de Londres. Paris: Fournier Fils, 1804.
  36. ^ a b Albert, D. J. (1966). The effect of spreading depression on the consolidation of learning. Neuropsychologia, 4.
  37. ^ Ruffini, Giulio; Wendling, Fabrice; Merlet, Isabelle; Molaee-Ardekani, Behnam; Mekonnen, Abeye; Salvador, Ricardo; Soria-Frisch, Aureli; Grau, Carles; Dunne, Stephen; Miranda, Pedro C. (2013). "Transcranial Current Brain Stimulation (tCS): Models and Technologies". IEEE Transactions on Neural Systems and Rehabilitation Engineering. 21 (3): 333–45. CiteSeerX 10.1.1.352.4406. doi:10.1109/TNSRE.2012.2200046. PMID 22949089.
  38. ^ Brunoni, Andre R.; Moffa, Adriano H.; Sampaio-Junior, Bernardo; Borrione, Lucas; Moreno, Marina L.; Fernandes, Raquel A.; Veronezi, Beatriz P.; Nogueira, Barbara S.; Aparicio, Luana V. M. (2017-06-28). "Trial of Electrical Direct-Current Therapy versus Escitalopram for Depression". New England Journal of Medicine. 376 (26): 2523–2533. doi:10.1056/nejmoa1612999. PMID 28657871.
  39. ^ a b Mondino M; et al. (May 2014). "Can transcranial direct current stimulation (tDCS) alleviate symptoms and improve cognition in psychiatric disorders?". World J Biol Psychiatry. 15 (4): 261–75. doi:10.3109/15622975.2013.876514. PMID 24447054.
  40. ^ Lefaucheur, Jean-Pascal; Antal, Andrea; Ayache, Samar S.; Benninger, David H.; Brunelin, Jérôme; Cogiamanian, Filippo; Cotelli, Maria; Ridder, Dirk De; Ferrucci, Roberta (2017). "Evidence-based guidelines on the therapeutic use of transcranial direct current stimulation (tDCS)". Clinical Neurophysiology. 128 (1): 56–92. doi:10.1016/j.clinph.2016.10.087. hdl:10067/1420300151162165141. PMID 27866120.
  41. ^ Coffman, Brian A.; Clark, Vincent P.; Parasuraman, Raja (2014). "Battery powered thought: Enhancement of attention, learning, and memory in healthy adults using transcranial direct current stimulation". NeuroImage. 85: 895–908. doi:10.1016/j.neuroimage.2013.07.083. PMID 23933040.
  42. ^ Dedoncker, Josefien; Brunoni, Andre R.; Baeken, Chris; Vanderhasselt, Marie-Anne (2016). "A Systematic Review and Meta-Analysis of the Effects of Transcranial Direct Current Stimulation (TDCS) over the Dorsolateral Prefrontal Cortex in Healthy and Neuropsychiatric Samples: Influence of Stimulation Parameters". Brain Stimulation. 9 (4): 501–517. doi:10.1016/j.brs.2016.04.006. hdl:1854/LU-7206618. PMID 27160468.
  43. ^ Hill, Aron T.; Fitzgerald, Paul B.; Hoy, Kate E. (2016). "Effects of Anodal Transcranial Direct Current Stimulation on Working Memory: A Systematic Review and Meta-Analysis of Findings from Healthy and Neuropsychiatric Populations". Brain Stimulation. 9 (2): 197–208. doi:10.1016/j.brs.2015.10.006. PMID 26597929.
  44. ^ Katsoulaki, Marianna; Kastrinis, Alexandros; Tsekoura, Maria (2017). "The Effects of Anodal Transcranial Direct Current Stimulation on Working Memory". GeNe Dis 2016. Advances in Experimental Medicine and Biology. Vol. 987. pp. 283–289. doi:10.1007/978-3-319-57379-3_25. ISBN 978-3-319-57378-6. PMID 28971466.
  45. ^ a b Horvath, Jared; Forte, Jason; Carter, Olivia (2015). "Evidence that transcranial direct current stimulation (tDCS) generates little-to-no reliable neurophysiologic effect beyond MEP amplitude modulation in healthy human subjects: A systematic review". Neuropsychologia. 66: 213–36. doi:10.1016/j.neuropsychologia.2014.11.021. PMID 25448853.
  46. ^ a b c Horvath, Jared; Forte, Jason; Carter, Olivia (2015). "Quantitative Review Finds No Evidence of Cognitive Effects in Healthy Populations From Single-session Transcranial Direct Current Stimulation (tDCS)". Brain Stimulation. 8 (3): 535–50. doi:10.1016/j.brs.2015.01.400. PMID 25701175.
  47. ^ Chhatbar, Pratik Y.; Feng, Wuwei (2015). "Data Synthesis in Meta-Analysis may Conclude Differently on Cognitive Effect from Transcranial Direct Current Stimulation". Brain Stimulation. 8 (5): 974–976. doi:10.1016/j.brs.2015.06.001. PMID 26115775.
  48. ^ Bernhard Elsner, Joachim Kugler, Marcus Pohl, Jan Mehrholz (2016). "Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people after stroke". Cochrane Database of Systematic Reviews. 3: CD009645. doi:10.1002/14651858.CD009645.pub3. PMC 6464909. PMID 26996760. At the moment, evidence of very low to moderate quality is available on the effectiveness of tDCS (anodal/cathodal/dual) versus control (sham/any other intervention) for improving ADL performance after stroke.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  49. ^ Boggio, Paulo S.; Rigonatti, Sergio P.; Ribeiro, Rafael B.; Myczkowski, Martin L.; Nitsche, Michael A.; Pascual-Leone, Alvaro; Fregni, Felipe (2007). "A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression". The International Journal of Neuropsychopharmacology. 11 (2): 249–54. doi:10.1017/S1461145707007833. PMC 3372849. PMID 17559710.
  50. ^ Loo, Colleen K.; Sachdev, Perminder; Martin, Donel; Pigot, Melissa; Alonzo, Angelo; Malhi, Gin S.; Lagopoulos, Jim; Mitchell, Philip (2009). "A double-blind, sham-controlled trial of transcranial direct current stimulation for the treatment of depression". The International Journal of Neuropsychopharmacology. 13 (1): 61–9. doi:10.1017/S1461145709990411. PMID 19671217.
  51. ^ Fregni, Felipe; Boggio, Paulo S.; Nitsche, Michael A.; Rigonatti, Sergio P.; Pascual-Leone, Alvaro (2006). "Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression". Depression and Anxiety. 23 (8): 482–4. doi:10.1002/da.20201. PMID 16845648.
  52. ^ Ferrucci, R.; Bortolomasi, M.; Vergari, M.; Tadini, L.; Salvoro, B.; Giacopuzzi, M.; Barbieri, S.; Priori, A. (2009). "Transcranial direct current stimulation in severe, drug-resistant major depression". Journal of Affective Disorders. 118 (1–3): 215–9. doi:10.1016/j.jad.2009.02.015. PMID 19286265.
  53. ^ Nitsche, Michael A.; Boggio, Paulo S.; Fregni, Felipe; Pascual-Leone, Alvaro (2009). "Treatment of depression with transcranial direct current stimulation (tDCS): A Review". Experimental Neurology. 219 (1): 14–9. doi:10.1016/j.expneurol.2009.03.038. PMID 19348793.
  54. ^ Fregni, Felipe; Boggio, Paulo S; Nitsche, Michael A; Marcolin, Marco A; Rigonatti, Sergio P; Pascual-Leone, Alvaro (2006). "Treatment of major depression with transcranial direct current stimulation". Bipolar Disorders. 8 (2): 203–4. doi:10.1111/j.1399-5618.2006.00291.x. PMID 16542193.
  55. ^ Vercammen, A.; Rushby, J.; Loo, C.; Short, B.; Weickert, C.S.; Weickert, T.W. (2011). "Transcranial direct current stimulation influences probabilistic association learning in schizophrenia". Schizophrenia Research. 131 (1–3): 198–205. doi:10.1016/j.schres.2011.06.021. PMID 21745726.
  56. ^ Adee, Sally (6 February 2012). "Zap Your Brain Into the Fast Track". New Scientist. Retrieved November 2, 2013.
  57. ^ Pedron, Solène; Monnin, Julie; Haffen, Emmanuel; Sechter, Daniel; Van Waes, Vincent (24 October 2013). "Repeated Transcranial Direct Current Stimulation Prevents Abnormal Behaviors Associated with Abstinence from Chronic Nicotine Consumption". Neuropsychopharmacology. 39 (4): 981–8. doi:10.1038/npp.2013.298. PMC 3924532. PMID 24154668.
  58. ^ Jansen, JM; Daams, JG; Koeter, MW; Veltman, DJ; van den Brink, W; Goudriaan, AE (December 2013). "Effects of non-invasive neurostimulation on craving: A meta-analysis". Neuroscience and Biobehavioral Reviews. 37 (10 Pt 2): 2472–80. doi:10.1016/j.neubiorev.2013.07.009. PMID 23916527.
  59. ^ Boldt I; et al. (Nov 2014). "Non-pharmacological interventions for chronic pain in people with spinal cord injury". Cochrane Database Syst Rev. 11 (11): CD009177. doi:10.1002/14651858.CD009177.pub2. PMID 25432061.
  60. ^ Elsner, B; Kugler, J; Pohl, M; Mehrholz, J (21 May 2019). "Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke". The Cochrane Database of Systematic Reviews. 5: CD009760. doi:10.1002/14651858.CD009760.pub4. PMC 6528187. PMID 31111960.
  61. ^ a b de Aguiar V; et al. (Feb 2015). "tDCS in post-stroke aphasia: The role of stimulation parameters, behavioral treatment and patient characteristics". Cortex. 63C: 296–316. doi:10.1016/j.cortex.2014.08.015. PMID 25460496.
  62. ^ Harty S, Robertson IH, Miniussi C, Sheehy OC, Devine CA, McCreery S, O'Connell RG (Mar 2014). "Transcranial direct current stimulation over right dorsolateral prefrontal cortex enhances error awareness in older age" (PDF). J Neurosci. 34 (10): 3646–52. doi:10.1523/JNEUROSCI.5308-13.2014. PMC 6608991. PMID 24599463.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  63. ^ Grimaldi, Giuliana; Argyropoulos, Georgios P.; Bastian, Amy; Cortes, Mar; Davis, Nicholas J.; Edwards, Dylan J.; Ferrucci, Roberta; Fregni, Felipe; Galea, Joseph M.; Hamada, Masahi; Manto, Mario; Miall, R. Chris; Morales-Quezada, Leon; Pope, Paul A.; Priori, Alberto; Rothwell, John; Tomlinson, S. Paul; Celnik, Pablo (2016). "Cerebellar Transcranial Direct Current Stimulation (CTDCS)". The Neuroscientist. 22 (1): 83–97. doi:10.1177/1073858414559409. PMC 4712385. PMID 25406224.
  64. ^ van Dun, Kim; Bodranghien, Florian C. A. A.; Mariën, Peter; Manto, Mario U. (2016-01-01). "tDCS of the Cerebellum: Where Do We Stand in 2016? Technical Issues and Critical Review of the Literature". Frontiers in Human Neuroscience. 10: 199. doi:10.3389/fnhum.2016.00199. PMC 4862979. PMID 27242469.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  65. ^ van Dun, Kim; Bodranghien, Florian; Manto, Mario; Mariën, Peter (2016-12-28). "Targeting the Cerebellum by Noninvasive Neurostimulation: a Review". The Cerebellum. 16 (3): 695–741. doi:10.1007/s12311-016-0840-7. ISSN 1473-4222. PMID 28032321.
  66. ^ "FDA Executive Summary - Petitions to Request Change in Classification for Cranial Electrotherapy Stimulators" (PDF).
Retrieved from "https://en.wikipedia.org/w/index.php?title=Transcranial_direct-current_stimulation&oldid=963903095"